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The two alleles of a gene are usually expressed equally in a normal cell, however, high incidence of allele-specific 
imbalance is frequently observed in cancer cells. Chromosomal regions with recurrent allele-specific imbalance 
usually harbor risk alleles and critical genes associated with cancer susceptibility and progression. With the 
development of large scale transcriptome sequencing technology, systematic analysis of the allele imbalance in 
the cancer transcriptome could be achieved at the single nucleotide resolution. In the April 2014 issue of 
Gastroenterology, we reported that the allele-specific imbalance of Oxidative Stress Induced Growth Inhibitor 1 
(OSGIN1) can significantly contribute to the progression of HCC. OSGIN1 is a stress-induced pro-apoptotic 
protein. By validating the sequencing results in a cohort of HCC patients, we found the variant 438H form of 
OSGIN1 was specifically overrepresented in the tumor tissues. Functional studies indicated that OSGIN1 has 
strong tumor suppressive function in HCC both in vitro and in vivo. The pro-apoptotic function of the variant 
form of OSGIN1 was found to be less potent than the wild-type form, and the functional defects might be due to 
its poor efficiency to localize to the mitochondria. Clinical pathological analysis further revealed that the 
expression and genotype of OSGIN1 are closely associated with the prognosis of HCC patients. Taken together, 
our study linked the stress-induced genes with allele imbalance in HCC transcriptome, and proposed OSGIN1 to 
be an important tumor suppressor gene in the progression of HCC. Further characterization of OSGIN1 might 
help predict the prognosis of HCC patients and their responses to chemotherapeutic drugs. 
To cite this article: Ming Liu, et al. Allele imbalance in the transcriptome of human hepatocellular carcinoma: stress-induced 
gene plays a role. Sci Proc 2014; 1: e382. doi: 10.14800/sp.382. 
 
The development of hepatocellular carcinoma (HCC) is a 
multi-step process, which involves accumulation of genetic 
and epigenetic alterations 
[1]
. Both individual genetic 
background and environmental factors interplay in the 
pathogenesis of HCC 
[2]
. Increasing evidences suggested that 
small changes in gene expression, which were regarded to be 
less-penetrant, might substantially contribution to cancer 
incidence and patient prognosis during cancer progression 
[3]
. 
The alleles with functional defects were usually 
overrepresented in cancer cells, which resulted in the 
allele-specific imbalance in the cancer transcriptome, and 
confer risk to the patients 
[4]
. In the April 2014 issue of 
Gastroenterology, we reported the allele-specific imbalance 
of Oxidative Stress Induced Growth Inhibitor 1 (OSGIN1) 
can significantly contribute to the progression of HCC. In 
this study, RNA sequencing technology was used to analyze 
the transcriptome of HCC tissues compared with their 
matched non-tumor liver tissues. High proportion of allele 
imbalance in genes related to cellular stress was identified. A 
novel nucleotide variation was found in the coding region of 
the gene OSGIN1. OSGIN1 was identified as a cell growth 
inhibitor in response to oxidative stress 
[5]
. The allele 
imbalance of OSGIN1 was frequently observed in a cohort of 
HCC patients, and the wild type allele was preferentially lost 
in the tumor tissue. Further functional assays indicated that 
the variant form of OSGIN1 might have functional defects, 
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and contributed to the poor prognosis of HCC patients 
[6]
. 
This study first linked the stress-induced genes with allele 
imbalance in HCC transcriptome, and proposed OSGIN1 to 
be an important tumor suppressor gene in the progression of 
HCC.  
Allele imbalance is a major hallmark of cancer. In a 
normal cell, the two alleles of a gene are usually expressed 
equally, however, high incidence of allele-specific imbalance 
is frequently observed in cancer patients 
[7]
. Loss of the 
wild-type MLH1 gene was found to be a feature of hereditary 
nonpolyposis colorectal cancer 
[8]
. In breast and ovarian 
cancer patients carrying BRCA1 mutation, the wild-type 
allele was also found to be selectively lost 
[9]
. Allele-specific 
deletions of chromosome3p were found to occur at the early 
stage in the pathogenesis of lung carcinoma 
[10]
. In colorectal 
cancer, LOH preferentially affects the normal allele of the 
well-known tumor suppressor APC, and the risk allele linked 
to disease is usually retained 
[3]
. Allele-specific expression 
analysis of APC has been proposed to be an important 
indicator of pathogenicity of familial adenomatous polyposis 
patients without APC mutations 
[11]
. In addition to APC, 
allele-specific expression of TGFBR1 which results in 
reduced expression of the gene also confers an increased risk 
of colorectal cancer 
[12]
. In addition to the increased cancer 
risk, the allele-specific imbalance also affects the prognosis 
and outcome of cancer patients. Selective loss of the Arg72 
allele and retention of the Pro72 allele of p53 was frequently 
observed in breast cancer and associated with poor overall 
survival of the patients, and the Arg72 p53 has been proved 
to be able to induce apoptosis at least five times better than 
the Pro72 p53 
[13, 14]
. The monoallelic expression of TP53 
and IDH1 has also been found to determine the oncogenic 
progression and outcome in benign and malignant brain 
tumors 
[15]
. Multiple molecular mechanisms such as 
allele-specific methylation (ASM), loss of heterozygosity 
and allele-specific transcription factor binding (ASTF) may 




With the development of large scale transcript me 
sequencing, systematic analysis of the allele imbalance in the 
cancer transcript me could be achieved at the single 
nucleotide resolution 
[18, 19]
. This technology greatly 
contributed to the identification of novel genetic alterations 
as well as the allele imbalance events in cancer patients. By 
sequencing the transcriptome of 3 paired HCC tissues, high 
proportion allele imbalance of the newly identified 
non-synonymous single nucleotide variations (SNVs) was 
found in the tumor tissues. Gene ontology analysis revealed 
that most of the affected genes are associated with signaling 
pathways related to cell cycle progression and cellular 
response to stress conditions. This indicated the importance 
of stress-induced genes in the pathogenesis of HCC. A 
nucleotide substitution from G to A at nt1494, which results 
in an amino acid substitution R438H, was identified in the 
coding region of OSGIN1. OSGIN1 was first identified as an 
oxidative stress induced growth inhibitor in mammary gland 
[5]
. Further studies indicated that the expression of OSGIN1 
could be significantly up-regulated upon DNA damage, and 
the activated OSGIN1 can enhance the permeability of 
mitochondria, thus inducing cell apoptosis 
[20, 21]
. OSGIN1 
can directly recruit p53 to mitochondria and the C terminal 
sequence of OSGIN1 is critical to its sub cellular localization 
[22]
. In this study, the genotype of OSGIN1 was examined in 
400 paired HCC tissues. The preferential retention of the 
variant form in the tumor tissues strongly indicated that it 
might have functional defects. Further in vitro functional 
assays and in vivo tumorigenic assays supported that the 
tumor suppressive functions of the variant form is less potent 
than the wild-type OSGIN1. The functional defect of the 
variant form might be caused by its poor efficiency to 
localize to the mitochondria. Interestingly, the staining of 
OSGIN1 showed a dot-scattered pattern in the healthy liver 
or para-tumor liver tissues. However, in the tumor tissues, 
the expression of OSGIN1 significantly decreased or 
restricted to the nucleus. The observation of OSGIN1 
staining in the clinical samples is in accordance with that in 
the cell line models. These indicated the localization of 
OSGIN1 is important for its function. In this study, OSGIN1 
was also linked to the chemo resistance to therapeutic drugs. 
The expression and genotype of OSGIN1 also significantly 
correlated with the prognosis of HCC patients. These 
findings suggested that further detection the expression or 
genotyping of OSGIN1 might help predict the outcome and 
the response to chemotherapeutic drugs of HCC patients.  
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